Share：
Share this content in WeChat
X
[Chinese][PDF]172959
• Original Article •
A study on the microstructure of hippocampus in Alzheimer's disease and amnestic mild cognitive impairment based on NODDI
WEI Zhihao  WANG Hong  JU Chao  LIU Ying 

Cite this article as: Wei ZH, Wang H, Ju C, et al. A study on the microstructure of hippocampus in Alzheimer's disease and amnestic mild cognitive impairment based on NODDI[J]. Chin J Magn Reson Imaging, 2022, 13(2): 26-30, 36. DOI:10.12015/issn.1674-8034.2022.02.006.


[Abstract] Objective Using neurite direction dispersion and density imaging (NODDI) to analyze the changes in the microstructure of the bilateral hippocampus in patients with Alzheimer's disease (AD) and amnestic mild cognitive impairment (aMCI), to provide more information on the pathogenesis of AD and explore clinical value of NODDI technology for AD and aMCI.Materials and Methods Fifteen patients with aMCI, 20 patients with AD and 20 normal controls (NC) was recruited for prospective NODDI scanning, using MRIcro software to measure the three groups of bilateral hippocampal neurite density index (NDI), neurite direction dispersion index (ODI), and volume fraction of isotropic water molecule (Viso). The differences of each parameter among the three groups using single-factor analysis of variance was compared, LSD was used to test the differences between groups. For the different parameters, Spearman correlation analysis was used to analyze the correlation between the parameters and the MMSE score and the MoCA score to obtain the correlation coefficient r.Results Compared with the NC group, the bilateral hippocampal NDI value and ODI value of the aMCI group and the AD group were significantly lower than the NC group, the difference was statistically significant (P＜0.001); the Viso value was significantly higher than the NC group, and the difference was also statistically significant (P＜0.001). The aMCI group and the AD group were compared between the groups. The Viso value of the AD group was significantly higher than that of the aMCI group, and the difference was statistically significant (P＜0.001), while the difference between the NDI value and the ODI value was not statistically significant (P＞0.05). Correlation analysis shows that the left hippocampal NDI value (r=0.656, P＜0.001) have the strongest positive correlation with the MMSE score, and the left Viso value (r=-0.690, P＜0.001) has the strongest negative correlation with MMSE score; at the same time, the left hippocampal NDI value (r=0.632, P＜0.001) has the strongest positive correlation with MoCA score, and the left Viso value (r=-0.629, P＜0.001) has the strongest negative correlation with MoCA.Conclusions The number, volume and arrangement complexity of bilateral hippocampal neurites in the aMCI stage and AD stage are significantly reduced, which provides more reference data for exploring the pathogenesis of AD. At the same time, during the progression of aMCI to AD, the bilateral hippocampal Viso value may become an important evaluation index, which has important value for the identification, follow-up and prognosis evaluation of aMCI and AD.
[Keywords] Alzheimer's disease；mild cognitive impairment；hippocampus；neurite direction dispersion；neurite density；neurite direction dispersion and density imaging；magnetic resonance imaging

WEI Zhihao   WANG Hong   JU Chao   LIU Ying*  

Imaging Center of the Second Affiliated Hospital of Xinjiang Medical University, Urumqi 830063, China

Liu Y, E-mail: 83982239@qq.com

Conflicts of interest   None.

ACKNOWLEDGMENTS Natural Science Foundation of Xinjiang Uygur Autonomous Region (No. 2020D01C191).
Received  2021-08-19
Accepted  2022-01-12
DOI: 10.12015/issn.1674-8034.2022.02.006
Cite this article as: Wei ZH, Wang H, Ju C, et al. A study on the microstructure of hippocampus in Alzheimer's disease and amnestic mild cognitive impairment based on NODDI[J]. Chin J Magn Reson Imaging, 2022, 13(2): 26-30, 36. DOI:10.12015/issn.1674-8034.2022.02.006.

[1]
Wei ZH, Wang H. Research progress of neurite direction dispersion and density imaging in Alzheimer's disease[J]. Chin J Magn Reson Imaging, 2021, 12(4): 103-105. DOI: 10.12015/issn.1674-8034.2021.04.026.
[2]
Petersen RC. Mild cognitive impairment as a diagnostic entity[J]. J Intern Med. 2004, 256(3): 183-194. DOI: 10.1111/j.1365-2796.2004.01388.x.
[3]
Inui Y, Ito K, Kato T, et al. Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study[J]. J Alzheimers Dis, 2017, 60(3): 877-887. DOI: 10.3233/JAD-170395.
[4]
Levey A, Lah J, Goldstein F, et al. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease[J]. Clin Ther, 2006, 28(7): 991-1001. DOI: 10.1016/j.clinthera.2006.07.006.
[5]
Sachdev PS, Lipnicki DM, Crawford J, et al. Factors predicting reversion from mild cognitive impairment to normal cognitive functioning: a population-based study[J]. PLoS One, 2013, 8(3): e59649. DOI: 10.1371/journal.pone.0059649.
[6]
Zhang H, Schneider T, Wheeler-Kingshott CA, et al. NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain[J]. Neuroimage, 2012, 61(4): 1000-1016. DOI: 10.1016/j.neuroimage.2012.03.072.
[7]
Contador J, Pérez-Millán A, Tort-Merino A, et al. Alzheimer's Disease Neuroimaging Initiative. Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimer's disease[J]. Neuroimage Clin, 2021, 32: 102804. DOI: 10.1016/j.nicl.2021.102804.
[8]
van de Mortel LA, Thomas RM, van Wingen GA, et al. Grey Matter Loss at Different Stages of Cognitive Decline: A Role for the Thalamus in Developing Alzheimer's Disease. J Alzheimers Dis, 2021, 83(2): 705-720. DOI: 10.3233/JAD-210173.
[9]
Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes[J]. Acta Neuropathol, 1991, 82(4): 239-259. DOI: 10.1007/BF00308809.
[10]
Arriagada PV, Growdon JH, Hedley-Whyte ET, et al. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease[J]. Neurology, 1992, 42(3Pt 1): 631-639. DOI: 10.1212/wnl.42.3.631.
[11]
Welsh K, Butters N, Hughes J, et al. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures[J]. Arch Neurol, 1991, 48(3): 278-281. DOI: 1001/archneur.1991.00530150046016.
[12]
Martensson G, Hakansson C, Pereira JB, et al. Medial temporal atrophy in preclinical dementia: Visual and automated assessment during six year follow-up[J]. Neuroimage Clin, 2020, 27: 102310. DOI: 10.1016/j.nicl.2020.102310.
[13]
Vogt NM, Hunt JF, Adluru N, et al. Cortical Microstructural Alterations in Mild Cognitive Impairment and Alzheimer's Disease Dementia[J]. Cereb Cortex, 2020, 30(5): 2948-2960. DOI: 10.1093/cercor/bhz286.
[14]
Parker TD, Slattery CF, Zhang J, et al. Cortical microstructure in young onset Alzheimer's disease using neurite orientation dispersion and density imaging[J]. Hum Brain Mapp, 2018, 39(7): 3005-3017. DOI: 10.1002/hbm.24056.
[15]
Zhou Y, Si XP, Chen YY, et al. Hippocampus-and Thalamus-Related Fiber-Specific White Matter Reductions in Mild Cognitive Impairment[J]. Cereb Cortex, 2021, bhab407. DOI: 10.1093/cercor/bhab407.
[16]
Xu L, Zhou Y, Hu L, et al. Deficits in N-Methyl-D-Aspartate Receptor Function and Synaptic Plasticity in Hippocampal CA1 in APP/PS1 Mouse Model of Alzheimer's Disease[J]. Front Aging Neurosci, 2021, 13: 772980. DOI: 10.3389/fnagi.2021.772980.
[17]
Sone D, Shigemoto Y, Ogawa M, et al. Association between neurite metrics and tau/inflammatory pathology in Alzheimer's disease[J]. Alzheimers Dement (Amst), 2020, 12(1): e12125. DOI: 10.1002/dad2.12125.
[18]
Fu X, Shrestha S, Sun M, et al. Microstructural White Matter Alterations in Mild Cognitive Impairment and Alzheimer's Disease : Study Based on Neurite Orientation Dispersion and Density Imaging (NODDI)[J]. Clin Neuroradiol, 2020, 30(3): 569-579. DOI: 10.1007/s00062-019-00805-0.
[19]
Devanand DP, Bansal R, Liu J, et al. MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease[J]. Neuroimage, 2012, 60(3): 1622-1629. DOI: 10.1016/j.neuroimage.2012.01.075.
[20]
Ge XT, Wu C, Xu K. Research on the correlation between the volume of hippocampal structure subregions and Tau lesions and cognitive impairment based on ADNI data[J]. Radiologic Practice, 2020, 35(12):1493-1498. DOI: 10.13609/j.cnki.1000-0313.2020.12.001.
[21]
Yang J, Pan P, Song W, et al. Voxelwise meta-analysis of gray matter anomalies in Alzheimer's disease and mild cognitive impairment using anatomic likelihood estimation[J]. J Neurol Sci, 2012, 316(1-2): 21-29. DOI: 10.1016/j.jns.2012.02.010.
[22]
Zhang J, Liu Y, Lan K, et al. Gray Matter Atrophy in Amnestic Mild Cognitive Impairment: A Voxel-Based Meta-Analysis[J]. Front Aging Neurosci, 2021, 13: 627919. DOI: 10.3389/fnagi.2021.627919.
[23]
Lombardi G, Crescioli G, Cavedo E, et al. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment[J]. Cochrane Database Syst Rev, 2020, 3(3): CD009628. DOI: 10.1002/14651858.CD009628.pub2.
[24]
Balestrieri JVL, Nonato MB, Gheler L, et al. Structural Volume of Hippocampus and Alzheimer's Disease[J]. Rev Assoc Med Bras (1992), 2020, 66(4): 512-515. DOI: 10.1590/1806-9282.66.4.512.

PREV A fMRI study of hippocampal functional connectivity changes in benign childhood epilepsy with centrotemporal spikes
NEXT Changes of resting-state brain functional activities in breast cancer patients after neoadjuvant chemotherapy: a short-term longitudinal study
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn